Can-Fite BioPharma Generates Partnership Interest at Therapeutic Area ...

20-11-2013 PR NewswireComments (0)

BiotechnologyCan-Fite BioPharmaInflammatory diseasesOncology

Can-Fite BioPharma (NYSE MKT: CANF), (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address anti-inflammatory and cancer diseases, has just ...

Read more on PR Newswire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top